Hong Yao

1.8k total citations
57 papers, 1.4k citations indexed

About

Hong Yao is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Hong Yao has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 15 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Hong Yao's work include Bioactive Natural Diterpenoids Research (10 papers), Ubiquitin and proteasome pathways (9 papers) and Peptidase Inhibition and Analysis (8 papers). Hong Yao is often cited by papers focused on Bioactive Natural Diterpenoids Research (10 papers), Ubiquitin and proteasome pathways (9 papers) and Peptidase Inhibition and Analysis (8 papers). Hong Yao collaborates with scholars based in China, United Kingdom and United States. Hong Yao's co-authors include Jinyi Xu, Shengtao Xu, Zheying Zhu, Hequan Yao, Junkai Liu, Zhe‐Sheng Chen, Dong‐Hua Yang, Dahong Li, Shaowen Xie and Jinhui Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

Hong Yao

52 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong Yao China 24 856 524 209 167 157 57 1.4k
Marta Świtalska Poland 24 700 0.8× 625 1.2× 134 0.6× 158 0.9× 66 0.4× 89 1.4k
Theodore Johnson United States 15 936 1.1× 454 0.9× 139 0.7× 181 1.1× 81 0.5× 17 1.5k
Hamed I. Ali Egypt 27 675 0.8× 786 1.5× 323 1.5× 141 0.8× 74 0.5× 60 1.6k
Keguang Cheng China 18 805 0.9× 328 0.6× 103 0.5× 65 0.4× 178 1.1× 58 1.2k
Alessandra Ammazzalorso Italy 24 837 1.0× 634 1.2× 144 0.7× 127 0.8× 65 0.4× 90 1.6k
Arunasree M. Kalle India 22 662 0.8× 735 1.4× 230 1.1× 174 1.0× 61 0.4× 43 1.7k
Midori A. Arai Japan 27 1.3k 1.6× 877 1.7× 373 1.8× 187 1.1× 168 1.1× 138 2.5k
Jian Ding China 19 746 0.9× 287 0.5× 238 1.1× 211 1.3× 113 0.7× 39 1.5k
Huibin Zhang China 23 774 0.9× 464 0.9× 77 0.4× 248 1.5× 74 0.5× 91 1.6k

Countries citing papers authored by Hong Yao

Since Specialization
Citations

This map shows the geographic impact of Hong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Yao more than expected).

Fields of papers citing papers by Hong Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Yao. The network helps show where Hong Yao may publish in the future.

Co-authorship network of co-authors of Hong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Hong Yao. A scholar is included among the top collaborators of Hong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong Yao. Hong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Congrong, Li Han, Hong Yao, et al.. (2025). Modulating G6PD/PGD to overcome FSP1/DHODH‐mediated ferroptosis defence: A novel oridonin derivative suppresses liver cancer. British Journal of Pharmacology. 183(2). 249–267.
2.
Zhu, Jingjie, Jia Xie, Fang Tian, et al.. (2025). Development of Adamantane-based hydrophobic tags targeting anaplastic lymphoma kinase with enhanced antitumor activities. Bioorganic Chemistry. 164. 108876–108876. 1 indexed citations
3.
Wang, Peng, Huajian Zhu, Shengtao Xu, et al.. (2024). Discovery of MT-1207: A Novel, Potent Multitarget Inhibitor as a Promising Clinical Candidate for the Treatment of Hypertension. Journal of Medicinal Chemistry. 67(18). 16128–16144.
4.
Li, Jinlong, Tong Zhang, Di Wu, et al.. (2024). Palladium-Mediated Bioorthogonal System for Prodrug Activation of N-Benzylbenzamide-Containing Tubulin Polymerization Inhibitors for the Treatment of Solid Tumors. Journal of Medicinal Chemistry. 67(21). 19905–19924. 1 indexed citations
5.
Xie, Shaowen, Jingjie Zhu, Yihan Peng, et al.. (2024). In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy. Angewandte Chemie International Edition. 64(11). e202421713–e202421713. 8 indexed citations
6.
Li, Xinnan, Lihua Liu, Tao Wang, et al.. (2023). Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase. Journal of Medicinal Chemistry. 66(7). 5118–5153. 12 indexed citations
7.
Liu, Junkai, Shaowen Xie, Hongyu Wu, et al.. (2022). Identification of new potent anticancer derivatives through simplifying the core structure and modification on their 14- hydroxyl group from oridonin. European Journal of Medicinal Chemistry. 231. 114155–114155. 13 indexed citations
8.
Liu, Lihua, et al.. (2022). Current development of bicyclic peptides. Chinese Chemical Letters. 34(6). 108026–108026. 11 indexed citations
9.
Xie, Shaowen, Yuan Sun, Yulin Liu, et al.. (2021). Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). Journal of Medicinal Chemistry. 64(13). 9120–9140. 55 indexed citations
10.
Xu, Shengtao, Hong Yao, Dahong Li, et al.. (2021). Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 64(23). 17346–17365. 27 indexed citations
11.
Zhu, Huajian, Wenlong Li, Shuai Wen, et al.. (2021). Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities. European Journal of Medicinal Chemistry. 216. 113316–113316. 26 indexed citations
12.
Yao, Hong, Shaowen Xie, Xiaoqian Ma, et al.. (2020). Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 63(15). 8157–8178. 37 indexed citations
13.
Liu, Junkai, Hong Yao, Xinnan Li, et al.. (2020). Organocatalytic 1,5-trifluoromethylthio-sulfonylation of vinylcyclopropane mediated by visible light in the water phase. Organic Chemistry Frontiers. 7(11). 1314–1320. 28 indexed citations
14.
Li, Wenlong, Feijie Xu, Shuai Wen, et al.. (2018). Discovery of Novel Quinoline–Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity. Journal of Medicinal Chemistry. 62(2). 993–1013. 108 indexed citations
15.
Li, Wenlong, Ying Yin, Hong Yao, et al.. (2018). Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities. European Journal of Medicinal Chemistry. 157. 1068–1080. 34 indexed citations
16.
Xu, Shengtao, Hong Yao, Shanshan Luo, et al.. (2017). A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway. Journal of Medicinal Chemistry. 60(4). 1449–1468. 97 indexed citations
17.
Xu, Shengtao, Hong Yao, Mei Hu, et al.. (2017). 6,7-Seco-ent-Kauranoids Derived from Oridonin as Potential Anticancer Agents. Journal of Natural Products. 80(9). 2391–2398. 29 indexed citations
18.
Xu, Shengtao, Guangyu Wang, Yan Lin, et al.. (2016). Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies. Bioorganic & Medicinal Chemistry Letters. 26(12). 2795–2800. 27 indexed citations
19.
Yao, Hong, et al.. (2016). Enantioselective Assembly of Spirolactones through NHC-Catalyzed Remote γ-Carbon Addition of Enals with Isatins. ACS Combinatorial Science. 18(5). 220–224. 21 indexed citations
20.
Yao, Hong, et al.. (2016). Enantioselective N‐Heterocyclic Carbene‐Catalyzed [3+3] Annulation of α,β‐Unsaturated Esters with Methyl Ketoimine. Advanced Synthesis & Catalysis. 358(11). 1864–1869. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Świtalska Breakdown of academic impact, for papers by Theodore Johnson Breakdown of academic impact, for papers by Hamed I. Ali Breakdown of academic impact, for papers by Keguang Cheng Breakdown of academic impact, for papers by Alessandra Ammazzalorso Breakdown of academic impact, for papers by Arunasree M. Kalle Breakdown of academic impact, for papers by Midori A. Arai Breakdown of academic impact, for papers by Jian Ding Breakdown of academic impact, for papers by Huibin Zhang
Rankless by CCL
2026